<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
EDIT
Editas Medicine
$
()


  • Editas Medicine highlights 2024 anticipated milestones, strategic priorities

    1/8/2024 - 08:41am
  • Editas Medicine price target raised by $7 at Evercore ISI, here's why

    12/14/2023 - 08:22am
  • What You Missed On Wall Street This Morning

    12/13/2023 - 12:06pm
  • Editas Medicine, Vertex Pharmaceuticals enter license agreement for Cas9

    12/13/2023 - 09:02am
  • Editas Medicine price target raised by $5 at Truist, here's why

    12/12/2023 - 09:29am
  • Editas Medicine to hold a pharmaceutical update conference call

    12/11/2023 - 12:45pm
  • Editas presents new EDIT-301 safety and efficacy data in 17 patients

    12/11/2023 - 12:02pm
  • Editas Medicine to hold a pharmaceutical update conference call

    12/11/2023 - 04:55am
  • Editas Medicine to hold a pharmaceutical update conference call

    12/4/2023 - 17:12pm
  • Editas Medicine price target lowered to $10 from $12 at Barclays

    11/5/2023 - 19:11pm
  • What You Missed On Wall Street On Friday

    11/3/2023 - 16:14pm
  • What You Missed On Wall Street This Morning

    11/3/2023 - 12:00pm
  • Fly Intel: Pre-market Movers

    11/3/2023 - 09:02am
  • Editas Medicine reports Q3 EPS (55c), consensus (57c)

    11/3/2023 - 07:03am
  • Editas Medicine to present data from RUBY, EdiTHAL trials of EDIT-301

    11/2/2023 - 09:30am
dynamic_feed Breaking News